SG Americas Securities
ONCR

SG Americas Securities’s Oncorus, Inc. ONCR Stock Holding History

SG Americas Securities’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-126,525
Closed -$44K – 3432
2023
Q1 		$44K Buy
126,525
+53,833
+74% +$20.1K ﹤0.01% 3083
2022
Q4 		$18K Buy
72,692
+36,355
+100% +$20.7K ﹤0.01% 2946
2022
Q3 		$31K Buy
36,337
+23
+0.1% +$29 ﹤0.01% 3059
2022
Q2 		$46K Sell
36,314
-4,383
-11% -$5.95K ﹤0.01% 3276
2022
Q1 		$72K Sell
40,697
-307
-0.7% -$860 ﹤0.01% 2807
2021
Q4 		$216K Sell
41,004
-6,847
-14% -$53K ﹤0.01% 2632
2021
Q3 		$447K Buy
47,851
+13,541
+39% +$155K ﹤0.01% 2611
2021
Q2 		$473K Sell
34,310
-638
-2% -$9.85K ﹤0.01% 1965
2021
Q1 		$486K Buy
34,948
+25,845
+284% +$535K ﹤0.01% 2037
2020
Q4 		$294K Buy
+9,103
New +$211K ﹤0.01% 2384

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

SG Americas Securities's ONCR Position: Q2 2023 in Review

SG Americas Securities sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 126,525 shares — an estimated $44K sold.

SG Americas Securities first reported a position in ONCR in Q4 2020 and held it in 10 quarters. The position peaked at $486K in Q1 2021. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • SG Americas Securities reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • SG Americas Securities sold 126,525 Oncorus, Inc. shares in Q2 2023, an estimated $44K.
  • SG Americas Securities first reported a position in Oncorus, Inc. in Q4 2020 and held it in 10 quarters.
  • SG Americas Securities's Oncorus, Inc. position peaked at $486K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on SG Americas Securities's 13F filing for Q2 2023, filed 10 Jul 2023.